Cabot Corporation
NYSE:CBTChemicals - Specialty
+$0.96 today
- Market cap
- $3.80B
- Beta
- 0.83
- P/E (TTM)
- 16.3
- EPS (TTM)
- $5.48
- Dividend yield
- 2.04%
Volume 0.53M
Average 0.43M
CBT Free Cash Flow
Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.
Cabot CorporationNYSE: CBT
Free Cash Flow · Q3 FY2026 · quarter ended Jun 2026
Free cash flow declines year over year
Q3 FY2026 free cash flow of $37M fell 82.8% year over year, behind the -19.3% change in trailing-twelve-month free cash flow. Sequentially, it rose 15.6% from the prior quarter.
Context
- Free cash flow amounted to 10.5% of revenue in FY2025, down 0.8 pp from a year earlier.
- Free cash flow increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -82.8% toward the trailing-twelve-month pace of -19.3%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Free Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 391M USD
- Year-over-year change
- -13.3%
- 4-year CAGR
- +58.5%
| Period | Period end | Free Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | 391M | -13.3% |
| FY2024 | 2024-09-30 | 451M | +28.5% |
| FY2023 | 2023-09-30 | 351M | +416.2% |
| FY2022 | 2022-09-30 | (111M) | -279.0% |
| FY2021 | 2021-09-30 | 62M | — |
Free Cash Flow vs competitors
How CBT compares with its peers on the latest reported figures
- Peers report in different currencies, so free cash flow is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -19.3% is the 8th highest of 11, against a peer median of -8.4%.
- Free cash flow amounts to 7.7% of revenue for CBT, versus a peer median of 5.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| FY2026 | ZAR 11.76B ZAR | -8.8% | -13.9% | 4.4% | |
| LTM Jun 2026 | $739.49M USD | -7.9% | +21.3% | 17.3% | |
| LTM Jun 2026 | $708M USD | +12.0% | -14.3% | 7.3% | |
| LTM Jun 2026 | $281M USD | -19.3% | — | 7.7% | |
| LTM Jun 2026 | $103.84M USD | -32.9% | — | 13.7% | |
| LTM Sep 2026 | $102.7M USD | -32.0% | -12.7% | 3.0% | |
| LTM Aug 2026 | $100.03M USD | -17.6% | -1.4% | 2.8% | |
| LTM Aug 2026 | $97.57M USD | +17.0% | +2.2% | 14.2% | |
| LTM Sep 2026 | $92.53M USD | +17.5% | +43.6% | 8.1% | |
| LTM Jun 2026 | $43.06M USD | +181.0% | — | 1.3% | |
| LTM Jun 2026 | $4.48M USD | -92.9% | — | 0.3% | |
| Peer median (excluding CBT) | — | -8.4% | -1.4% | 5.9% | |
Competitors are the stored peer set for CBT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Net Income | 286M | 243M | 484M | 424M | 376M |
| Depreciation & Amortization | 160M | 146M | 144M | 151M | 154M |
| Deferred Income Tax | 9M | (40M) | (156M) | (37M) | 32M |
| Stock-Based Compensation | 21M | 23M | 20M | 25M | 24M |
| Change in Working Capital | (244M) | (448M) | 100M | 70M | 49M |
| Accounts Receivables | 7M | (287M) | 153M | (26M) | 76M |
| Inventory | (174M) | (259M) | 96M | 41M | 47M |
| Accounts Payables | 167M | 115M | (152M) | 42M | (67M) |
| Other Working Capital | (244M) | (17M) | 3M | 13M | (7M) |
| Other Non-Cash Items | 25M | 176M | 3M | 59M | 30M |
| Operating Cash Flow | 257M | 100M | 595M | 692M | 665M |
| Capital Expenditures | (195M) | (211M) | (244M) | (241M) | (274M) |
| Acquisitions (Net) | (92M) | 70M | 6M | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 101M | 23M | 24M | 6M | (24M) |
| Investing Cash Flow | (186M) | (118M) | (214M) | (235M) | (298M) |
| Debt Repayment | 36M | 298M | (179M) | (143M) | (23M) |
| Common Stock Issued | 6M | 6M | 4M | 20M | 8M |
| Common Stock Repurchased | (3M) | (53M) | (98M) | (172M) | (168M) |
| Dividends Paid | (80M) | (84M) | (88M) | (93M) | (96M) |
| Other Financing Activities | (19M) | (22M) | (42M) | (27M) | (57M) |
| Financing Cash Flow | (60M) | 145M | (403M) | (415M) | (336M) |
| Effect of Forex Changes | 8M | (91M) | 54M | (57M) | 4M |
| Net Change in Cash | 19M | 36M | 32M | (15M) | 35M |
| Free Cash Flow | 62M | (111M) | 351M | 451M | 391M |
Cabot Corporation
NYSE:CBT
Intrinsic Alpha fair value
Locked
Current Price
$74.03
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.